Found: 89
Select item for more details and to access through your institution.
Diagnostic Performance of CLEIA Versus FEIA for KL‐6 Peripheral and Alveolar Concentrations in Fibrotic Interstitial Lung Diseases: A Multicentre Study.
- Published in:
- Journal of Clinical Laboratory Analysis, 2024, v. 38, n. 17, p. 1, doi. 10.1002/jcla.25108
- By:
- Publication type:
- Article
Common Molecular Pathways Between Post-COVID19 Syndrome and Lung Fibrosis: A Scoping Review.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.748931
- By:
- Publication type:
- Article
Oxidant/Antioxidant Disequilibrium in Idiopathic Pulmonary Fibrosis Pathogenesis.
- Published in:
- Inflammation, 2020, v. 43, n. 1, p. 1, doi. 10.1007/s10753-019-01059-1
- By:
- Publication type:
- Article
A real-life experience with ImmunoCAP ISAC: the advantages of a new diagnostic method.
- Published in:
- Minerva Medica, 2023, v. 114, n. 1, p. 94, doi. 10.23736/S0026-4806.19.06408-5
- By:
- Publication type:
- Article
Prognostic role of KL-6 in lymphangioleiomyomatosis patients.
- Published in:
- Minerva Medica, 2022, v. 113, n. 4, p. 727, doi. 10.23736/S0026-4806.21.07322-5
- By:
- Publication type:
- Article
Neutrophil-to-lymphocyte ratio in bronchoalveolar lavage from IPF patients: a novel prognostic biomarker?
- Published in:
- Minerva Medica, 2022, v. 113, n. 3, p. 526, doi. 10.23736/S0026-4806.20.06614-8
- By:
- Publication type:
- Article
Peripheral lymphocyte subset monitoring in COVID-19 Italian patients.
- Published in:
- Minerva Medica, 2021, v. 112, n. 3, p. 423, doi. 10.23736/S0026-4806.20.06638-0
- By:
- Publication type:
- Article
The Effects of Interstitial Lung Diseases on Alveolar Extracellular Vesicles Profile: A Multicenter Study.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 4, p. 4071, doi. 10.3390/ijms24044071
- By:
- Publication type:
- Article
BAL Proteomic Signature of Lung Adenocarcinoma in IPF Patients and Its Transposition in Serum Samples for Less Invasive Diagnostic Procedures.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 2, p. 925, doi. 10.3390/ijms24020925
- By:
- Publication type:
- Article
PD1, CTLA4 and TIGIT Expression on T and NK Cells in Granulomatous Diseases: Sarcoidosis and ANCA-Associated Vasculitis.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 1, p. 256, doi. 10.3390/ijms24010256
- By:
- Publication type:
- Article
Extended Exhaled Nitric Oxide Analysis in Interstitial Lung Diseases: A Systematic Review.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 17, p. 6187, doi. 10.3390/ijms21176187
- By:
- Publication type:
- Article
Metabolic Dysregulation in Idiopathic Pulmonary Fibrosis.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 16, p. 5663, doi. 10.3390/ijms21165663
- By:
- Publication type:
- Article
Relapse of microscopic polyangiitis after vaccination against COVID‐19: A case report.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Peripheral biomarkers' panel for severe COVID‐19 patients.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 3, p. 1230, doi. 10.1002/jmv.26577
- By:
- Publication type:
- Article
Serum concentrations of Krebs von den Lungen‐6 in different COVID‐19 phenotypes.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 2, p. 657, doi. 10.1002/jmv.26431
- By:
- Publication type:
- Article
Serum KL‐6 concentrations as a novel biomarker of severe COVID‐19.
- Published in:
- Journal of Medical Virology, 2020, v. 92, n. 10, p. 2216, doi. 10.1002/jmv.26087
- By:
- Publication type:
- Article
Correction to: BAL biomarkers' panel for differential diagnosis of interstitial lung diseases.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
BAL biomarkers' panel for differential diagnosis of interstitial lung diseases.
- Published in:
- Clinical & Experimental Medicine, 2020, v. 20, n. 2, p. 207, doi. 10.1007/s10238-020-00608-5
- By:
- Publication type:
- Article
Characterization of NKG2-A/-C, Kir and CD57 on NK Cells Stimulated with pp65 and IE-1 Antigens in Patients Awaiting Lung Transplant.
- Published in:
- Life (2075-1729), 2022, v. 12, n. 7, p. 1081, doi. 10.3390/life12071081
- By:
- Publication type:
- Article
CD103 Expression on Regulatory and Follicular T Cells in Lymph Nodes, Bronchoalveolar Lavage Fluid and Peripheral Blood of Sarcoidosis Patients.
- Published in:
- Life (2075-1729), 2022, v. 12, n. 5, p. 762, doi. 10.3390/life12050762
- By:
- Publication type:
- Article
Neutrophil Extracellular Traps in ANCA-Associated Vasculitis and Interstitial Lung Disease: A Scoping Review.
- Published in:
- Life (2075-1729), 2022, v. 12, n. 2, p. N.PAG, doi. 10.3390/life12020317
- By:
- Publication type:
- Article
Extracellular Vesicles in Pulmonary Fibrosis Models and Biological Fluids of Interstitial Lung Disease Patients: A Scoping Review.
- Published in:
- Life (2075-1729), 2021, v. 11, n. 12, p. 1401, doi. 10.3390/life11121401
- By:
- Publication type:
- Article
Strain Echocardiography Is a Promising Tool for the Prognostic Assessment of Sarcoidosis.
- Published in:
- Life (2075-1729), 2021, v. 11, n. 10, p. 1065, doi. 10.3390/life11101065
- By:
- Publication type:
- Article
Characterization of natural killer and T cells in bronchoalveolar lavage and peripheral blood of sarcoidosis patients.
- Published in:
- Frontiers in Immunology, 2023, v. 13, p. 01, doi. 10.3389/fimmu.2022.1080556
- By:
- Publication type:
- Article
Prevalence of myositis specific and associated antibodies in a cohort of patients affected by idiopathic NSIP and no hint of inflammatory myopathies.
- Published in:
- Immunologic Research, 2023, v. 71, n. 5, p. 735, doi. 10.1007/s12026-023-09387-z
- By:
- Publication type:
- Article
Utility of serological biomarker' panels for diagnostic accuracy of interstitial lung diseases.
- Published in:
- Immunologic Research, 2020, v. 68, n. 6, p. 414, doi. 10.1007/s12026-020-09158-0
- By:
- Publication type:
- Article
The Role of Peamaclein (Pru p 7) in PFAS Patients: An Italian Real-Life Study.
- Published in:
- Allergies (2313-5786), 2023, v. 3, n. 3, p. 177, doi. 10.3390/allergies3030011
- By:
- Publication type:
- Article
A Comprehensive Evaluation of Mepolizumab Effectiveness in a Real-Life Setting.
- Published in:
- International Archives of Allergy & Immunology, 2020, v. 181, n. 8, p. 606, doi. 10.1159/000507996
- By:
- Publication type:
- Article
Personalized Approach of Severe Eosinophilic Asthma Patients Treated with Mepolizumab and Benralizumab.
- Published in:
- International Archives of Allergy & Immunology, 2020, v. 181, n. 10, p. 746, doi. 10.1159/000508936
- By:
- Publication type:
- Article
Krebs von den Lungen-6 as Disease Severity Marker for COVID-19 Patients: Analytical Verification and Quality Assessment of the Tosoh AIA-360 Compared to Lumipulse G600II.
- Published in:
- International Journal of Environmental Research & Public Health, 2022, v. 19, n. 4, p. 2176, doi. 10.3390/ijerph19042176
- By:
- Publication type:
- Article
Combined Sarcoidosis and Idiopathic Pulmonary Fibrosis (CSIPF): A New Phenotype or a Fortuitous Overlap? Scoping Review and Case Series.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 7, p. 2065, doi. 10.3390/jcm11072065
- By:
- Publication type:
- Article
Author reply.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Antithrombin III as predictive indicator of survival in idiopathic pulmonary fibrosis (IPF) patients treated with nintedanib: a preliminary study.
- Published in:
- Internal Medicine Journal, 2021, v. 51, n. 5, p. 705, doi. 10.1111/imj.14768
- By:
- Publication type:
- Article
Specificity of serum amyloid A as a biomarker of idiopathic pulmonary fibrosis.
- Published in:
- Internal Medicine Journal, 2020, v. 50, n. 12, p. 1571, doi. 10.1111/imj.15113
- By:
- Publication type:
- Article
Rituximab therapy in interstitial lung disease associated with rheumatoid arthritis.
- Published in:
- Internal Medicine Journal, 2020, v. 50, n. 3, p. 330, doi. 10.1111/imj.14306
- By:
- Publication type:
- Article
Peripheral and alveolar biomarkers of fibrotic hypersensitivity pneumonitis.
- Published in:
- Panminerva Medica, 2022, v. 64, n. 4, p. 548, doi. 10.23736/S0031-0808.20.04056-2
- By:
- Publication type:
- Article
Serum cd59: a novel biomarker of idiopathic pulmonary fibrosis?
- Published in:
- Panminerva Medica, 2021, v. 63, n. 2, p. 201, doi. 10.23736/S0031-0808.20.03893-8
- By:
- Publication type:
- Article
Oxygen Therapy during Exercise in Patients with Interstitial Lung Diseases.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 5, p. 717, doi. 10.3390/biom12050717
- By:
- Publication type:
- Article
Cytomegalovirus Infection Is Associated with Development of Chronic Lung Allograft Dysfunction.
- Published in:
- Lung, 2022, v. 200, n. 4, p. 513, doi. 10.1007/s00408-022-00551-0
- By:
- Publication type:
- Article
The Role of Galectins in Chronic Lung Allograft Dysfunction.
- Published in:
- Lung, 2021, v. 199, n. 3, p. 281, doi. 10.1007/s00408-021-00449-3
- By:
- Publication type:
- Article
Mepolizumab and Benralizumab in Severe Eosinophilic Asthma: Preliminary Results of a Proteomic Study.
- Published in:
- Lung, 2020, v. 198, n. 5, p. 761, doi. 10.1007/s00408-020-00379-6
- By:
- Publication type:
- Article
Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 689, doi. 10.3390/cancers13040689
- By:
- Publication type:
- Article
Systematic Review and Metanalysis of Oncomarkers in IPF Patients and Serial Changes of Oncomarkers in a Prospective Italian Real-Life Case Series.
- Published in:
- Cancers, 2021, v. 13, n. 3, p. 539, doi. 10.3390/cancers13030539
- By:
- Publication type:
- Article
Clinical and molecular characterization of COVID-19 hospitalized patients.
- Published in:
- PLoS ONE, 2020, v. 15, n. 11, p. 1, doi. 10.1371/journal.pone.0242534
- By:
- Publication type:
- Article
Idiopathic Pulmonary Fibrosis Serum proteomic analysis before and after nintedanib therapy.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-66296-z
- By:
- Publication type:
- Article
Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of Siena.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620906326
- By:
- Publication type:
- Article
Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of Siena.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, p. 1, doi. 10.1177/1753466620906326
- By:
- Publication type:
- Article
Multi-Omics Integrative Approach of Extracellular Vesicles: A Future Challenging Milestone.
- Published in:
- Proteomes, 2022, v. 10, n. 2, p. N.PAG, doi. 10.3390/proteomes10020012
- By:
- Publication type:
- Article
Adaptive immune system in pulmonary sarcoidosis—Comparison of peripheral and alveolar biomarkers.
- Published in:
- Clinical & Experimental Immunology, 2021, v. 205, n. 3, p. 406, doi. 10.1111/cei.13635
- By:
- Publication type:
- Article
Panel of serum biomarkers for differential diagnosis of idiopathic interstitial lung disease and interstitial lung disease-secondary to systemic autoimmune rheumatic disease.
- Published in:
- PLoS ONE, 2024, v. 19, n. 10, p. 1, doi. 10.1371/journal.pone.0311357
- By:
- Publication type:
- Article